Beyond therapeutic potential: a systematic investigation of ketamine misuse in patients with depressive disorders.
Discover mental health July 1, 2024 Keshav Juneja, Sabah Afroze, Zeel Goti et al. 6 citations
A systematic review examined the prevalence of ketamine abuse among people receiving ketamine treatment for major depressive disorder (MDD). The review, covering studies published between 2021 and 2023, found that reported abuse rates vary widely, underscoring the need for standardized definitions and assessment tools. The authors developed a novel screening questionnaire and assessment algorithm to identify ketamine misuse in MDD patients undergoing treatment. This tool aims to help healthcare professionals detect and address misuse promptly, improving patient safety and outcomes.